Bay Colony Advisory Group, Inc D Alkermes Plc. Transaction History

Bay Colony Advisory Group, Inc D

  • $634 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 01, 2023
BUY
$21.94 - $26.24 $767,900 - $918,400
35,000 Added 77.78%
80,000 $2.09 Million
Q4 2020

Feb 02, 2021
BUY
$15.39 - $22.1 $307,800 - $442,000
20,000 Added 80.0%
45,000 $898,000
Q3 2020

Nov 25, 2020
BUY
$16.16 - $20.66 $404,000 - $516,500
25,000 New
25,000 $414,000

Others Institutions Holding ALKS

# of Institutions
361
Shares Held
181M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.84B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Bay Colony Advisory Group, Inc D Portfolio

Follow Bay Colony Advisory Group, Inc D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bay Colony Advisory Group, Inc D, based on Form 13F filings with the SEC.

News

Stay updated on Bay Colony Advisory Group, Inc D with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email